These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23283580)

  • 1. Transglutaminases: future perspectives.
    Beninati S; Facchiano F; Piacentini M
    Amino Acids; 2013 Jan; 44(1):1-9. PubMed ID: 23283580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
    Martin A; Giuliano A; Collaro D; De Vivo G; Sedia C; Serretiello E; Gentile V
    Amino Acids; 2013 Jan; 44(1):111-8. PubMed ID: 21938398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase is linked to neurodegenerative diseases.
    Muma NA
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):258-63. PubMed ID: 17413316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminases in neurodegenerative disorders.
    Bailey CD; Tucholski J; Johnson GV
    Prog Exp Tumor Res; 2005; 38():139-57. PubMed ID: 15746534
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 2 transglutaminase and cell death.
    Piacentini M; Amendola A; Ciccosanti F; Falasca L; Farrace MG; Mastroberardino PG; Nardacci R; Oliverio S; Piredda L; Rodolfo C; Autuori F
    Prog Exp Tumor Res; 2005; 38():58-74. PubMed ID: 15746529
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue transglutaminase: apoptosis versus autoimmunity.
    Piacentini M; Colizzi V
    Immunol Today; 1999 Mar; 20(3):130-4. PubMed ID: 10203704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminases and receptor tyrosine kinases.
    Sivaramakrishnan M; Shooter GK; Upton Z; Croll TI
    Amino Acids; 2013 Jan; 44(1):19-24. PubMed ID: 21986960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases.
    Bailey CD; Graham RM; Nanda N; Davies PJ; Johnson GV
    Mol Cell Neurosci; 2004 Mar; 25(3):493-503. PubMed ID: 15033177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.
    Elli L; Bergamini CM; Bardella MT; Schuppan D
    Dig Liver Dis; 2009 Aug; 41(8):541-50. PubMed ID: 19195940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the Special Issue: Invited Papers from the 2015 APAHC Conference.
    Shaffer LA; Shahane AA
    J Clin Psychol Med Settings; 2015 Dec; 22(4):195-8. PubMed ID: 26604204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase as the agent of neurodegenerative diseases due to polyglutamine expansion.
    Kahlem P; Green H; Djian P
    Pathol Biol (Paris); 1998 Nov; 46(9):681-2. PubMed ID: 9885815
    [No Abstract]   [Full Text] [Related]  

  • 13. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders.
    Iismaa SE; Mearns BM; Lorand L; Graham RM
    Physiol Rev; 2009 Jul; 89(3):991-1023. PubMed ID: 19584319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [La Medicina del Lavoro: 100 volumes].
    Zocchetti C
    Med Lav; 2009; 100(1):3-10. PubMed ID: 19263867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to the Special Issue: Invited Papers from the 2017 APAHC Conference.
    Yozwiak JA; Williams AM; Cash ED
    J Clin Psychol Med Settings; 2018 Sep; 25(3):237-239. PubMed ID: 29411274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transglutaminases in neurodegenerative diseases: overview.
    Cooper AJ; Jeitner TM; Blass JP
    Neurochem Int; 2002 Jan; 40(1):1-5. PubMed ID: 11738467
    [No Abstract]   [Full Text] [Related]  

  • 17. Hippocampal polyamine levels and transglutaminase activity are paralleling spatial memory retrieval in the C57BL/6J mouse.
    Tiboldi A; Lentini A; Provenzano B; Tabolacci C; Höger H; Beninati S; Lubec G
    Hippocampus; 2012 May; 22(5):1068-74. PubMed ID: 22467251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of transglutaminase and other stress proteins during neurodegenerative processes.
    Caccamo D; Currò M; Condello S; Ferlazzo N; Ientile R
    Amino Acids; 2010 Feb; 38(2):653-8. PubMed ID: 19960212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to the 50th anniversary special issue on psychotherapy outcome: a return to the beginning.
    Hilsenroth MJ
    Psychotherapy (Chic); 2013 Mar; 50(1):1-2. PubMed ID: 23505973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifaceted role of transglutaminase in neurodegeneration: review article.
    Karpuj M; Steinman L
    Amino Acids; 2004 Jul; 26(4):373-9. PubMed ID: 15290343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.